Intrepid: Clinical Effectiveness of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Versus Multiple-Inhaler Triple Therapy in Usual Clinical Practice

Abstract

1University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK; 2GSK, Stevenage, Hertfordshire, UK; 3GSK, Collegeville, PA, USA; 4McMaster University, Hamilton, ON, Canada; 5GSK, Värmdö, Stockholm, Sweden; 6insaf Respiratory Research Institute, Wiesbaden, Germany; 7GSK, Stockley Park West, Uxbridge, Middlesex, UK; 8GSK, Brentford, Middlesex, UK; 9General Practitioners Research Institute, Groningen, the Netherlands; 10University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, the Netherlands; 11Observational and Pragmatic Research Institute, Singapore; 12University Hospital Miguel Servet, Zaragoza, Spain; 13King’s College, London, UK